Innoviva Inc

Innoviva Inc

INVA · NASDAQ
INVA · NASDAQ
18.41
USD-0.02-0.08%

Latest News

    SeekingAlpha

    Royalty Pharma to buy royalty interest in Trelegy drug from Theravance, Innoviva for $1.3B

      SeekingAlpha

      Innoviva to acquire La Jolla Pharma for $149M including debt

        SeekingAlpha

        Innoviva to acquire Entasis Therapeutics for $2.20/share

        Analysts Recommendations

        Bullish

        Buy

        Strong Buy

        Buy

        Hold

        Sell

        Strong Sell

        Day Range

        18.33USD
        18.79USD

        52 Week Range

        18.19USD
        25.14USD

        Market Cap

        1.31BUSD

        lock-imagelock-image

        Get Full Access with Profit PRO

        See which Billionaires own this investment

        About

        General Information

        Type

        Common Stock

        Exchange

        NASDAQ

        Currency Code

        USD

        Currency Name

        US Dollar

        Country Name

        USA

        Country ISO

        US

        ISIN

        US45781M1018

        CUSIP

        88338T104

        Sector

        Healthcare

        Industry

        Biotechnology

        Fiscal Year End

        December

        IPO date

        -

        Updated At

        -

        Highlights

        PE Ratio

        7.83

        PEG Ratio

        2.80

        Book Value

        15.90

        Dividend Share

        -

        Dividend Yield

        -

        Earnings Share

        2.35

        Wall Street Target Price

        33.83

        EPS Estimate Current Year

        0.79

        EPS Estimate Next Year

        2.06

        EPS Estimate Current Quarter

        0.34

        EPS Estimate Next Quarter

        0.522

        Most Recent Quarter

        -

        Profitability

        Revenue TTM

        438,318,016

        Gross Profit TTM

        337,372,992

        EBITDA

        199,807,008

        Profit Margin

        44.13%

        Return On Assets TTM

        7.29%

        Return On Equity TTM

        18.02%

        Revenue Per Share TTM

        5.953

        Qtly Revenue Growth YOY

        -1.60%

        Diluted Eps TTM

        2.35

        Qtly Earnings Growth YOY

        590.40%

        Valuation

        Trailing PE

        7.83

        Forward PE

        8

        Price Sales TTM

        2.9855

        Price Book MRQ

        1.1504

        Enterprise Value Revenue

        2

        Enterprise Value EBITDA

        3

        Peers analysis

        • argenx SE
          ARGNFargenx SE

          965.00

          0.00%
        • CSL Limited
          CMXHFCSL Limited

          128.26

          0.00%
        • Be
          ONCBeOne Medicines AG

          390.94

          -2.36%
        • UCB SA ADR
          UCBJYUCB SA ADR

          151.52

          -2.31%
        • argenx NV ADR
          ARGXargenx NV ADR

          925.70

          -1.93%
        • CSL Ltd
          CSLLYCSL Ltd

          32.39

          -1.88%
        • UCB SA
          UCBJFUCB SA

          318.32

          -1.17%
        • Vertex Pharmaceuticals Inc
          VRTXVertex Pharmaceuticals Inc

          516.11

          -1.04%
        • Regeneron Pharmaceuticals Inc
          REGNRegeneron Pharmaceuticals Inc

          917.00

          -0.91%
        • Moderna Inc
          MRNAModerna Inc

          199.30

          -0.11%

        FAQs

        What is Innoviva stock price today?

        What is Innoviva stock ticker?

        Is INVA stock price going up?

        What is the analyst recommendation for INVA?

        What is INVA market cap?

        Does INVA release financial reports?

        When is INVA next earnings date?

        What were INVA Earnings for the last quarter?

        What was INVA Revenue for the last quarter?

        What was INVA Net Income for the last quarter?

        Does INVA pay dividends?

        How many employees does INVA have?

        What is INVA EBITDA?

        How to buy INVA stocks?

        Should I invest in INVA stock?